Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Richards (Amsterdam, Netherlands), J. Van Bragt (Amsterdam, Netherlands), R. Aarab (Amsterdam, Netherlands), J. Sont (Leiden, Netherlands), E. Weersink (Amsterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands), E. Bel (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands). Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice. 2515

Member's Comments

No comment yet.

Related content which might interest you: Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Step-down of moderate-severe asthma treatment in clinical practice Source: International Congress 2018 – Asthma management Year: 2018 Implementation of questionnaires in the management of COPD patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013 Implementation of questionnaires in the management of asthma patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013 Clinical and functional effectiveness of roflumilast in severe COPD patients Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Spanish study on unmet clinical needs in patients with uncontrolled severe asthma. Source: International Congress 2018 – Asthma management Year: 2018 Mepolizumab eligibility in children with severe asthma – do we need paediatric specific criteria? Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017 Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE) Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Life-sustaining treatment preferences of patients with severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019 Educational program and clinical symptoms in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 285s Year: 2001 Clinical management of very severe COPD Source: Annual Congress 2008 - Update on long-term oxygen therapy in COPD Year: 2008